Federal judge denies Amgen's motion to dismiss Regeneron antitrust case
While Amgen and Regeneron’s spat before the Supreme Court goes forward on Amgen’s request to revive patents on its blockbuster Repatha and block the sale of Sanofi and Regeneron’s Praluent, another case is moving forward in federal court — this time Regeneron is pushing a case against Amgen and focusing on antitrust law.
Delaware Circuit Court Judge Richard Andrews overruled a petition from Amgen on Tuesday to dismiss the case (1:22-cv-00697-RGA-JLH), now allowing it to continue. Regeneron filed the case against Amgen last May.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.